Results 91 to 100 of about 27,042 (199)

Immunogenicity and Safety of a Full-Dose Regimen of Cell Culture-Derived Quadrivalent Inactivated Influenza Vaccine in Children Aged 6-35 Months: Results from a Multinational Phase 3 Randomised Controlled Trial. [PDF]

Vaccines (Basel)
Yoon Y, Cho HK, Kim KH, Park SE, Kim YJ, Lee J, Kim HM, Kim NH, Jo DS, Cho EY, Shin SH, Kim JH, Ryu JH, Park HK, Lee Y, Kim YK.   +15 more
europepmc   +1 more source

Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies. [PDF]

mBio
Singh G, Bhavsar D, Hermann E, Gleason C, Singh Sandhu H, Singh P, Nardulli JR, Lyttle N, Chen Y, Sabaiduc S, Peña Alzua G, Skowronski DM, Simon V, Krammer F.   +13 more
europepmc   +1 more source

Characterizing population-level short-term waning of newcastle disease humoral immunity of MDA-positive broiler chicks with day-old HB1 vaccination in Nigeria. [PDF]

Vet Anim Sci
Rabo N, Bako E, Audu M, Ibu J.
europepmc   +1 more source

Serological responses to killed oral cholera vaccine (OCV) when given 4 years after initial receipt of OCV in Cameroon: A randomized controlled trial. [PDF]

PLOS Glob Public Health
Ateudjieu J, Tchio-Nighie KH, Guenou E, Fokou C, Buh Nkum C, Beyala Bita'a L, Ateudjieu-Kenfack WD, Nanfak S, Debes AK, Sack DA.   +9 more
europepmc   +1 more source

SARS-CoV-2 Omicron infection reveals imprinted antibody responses in the absence of vaccination. [PDF]

iScience
Abdullahi A, Morse RB, Kin Cheng MT, Ige F, Onyemata J, Edun M, Kramna A, Sievers B, Turner S, Wisso H, Jonathan E, Balogun O, Salako A, Abdulazeez-Oha H, James A, Musa A, Oluwaseun O, Iwalokun B, Ezechi O, Anzaku A, Okpokoro E, Osawe S, Nwikue G, Kida IM, Musa BM, Murtala HA, Meng B, Rosenzweig L, Aliyu SH, Smith D, MacAry P, Doffinger R, Więcek W, Salako B, Tan CW, Abimiku A, Gupta RK.   +36 more
europepmc   +1 more source

Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years. [PDF]

Clin Infect Dis
Mitha E, Ferguson M, Wilhase AC, De Looze F, Vachon ML, Stacey H, Rasalam R, Nozaki M, Smith WB, Schwarz TF, Hailemariam HA, Deraedt Q, Gérard C, Vanden Abeele C, Damaso S, Descamps D, Hill J, Dasyam D, Van Gucht J, Hulstrøm V.   +19 more
europepmc   +1 more source

Presswerk Köngen champions GMT

Reinforced Plastics, 1994
openaire   +1 more source

Safety and Immunogenicity of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase III, Randomized, Blinded, Positive-Control Clinical Trial in Infants Aged Two Months. [PDF]

Vaccines (Basel)
Zhang H, Chen Y, Xu B, Tang R, Wang Y, Hu J, Yang S, Wei M, Li G, Liang Q.   +9 more
europepmc   +1 more source

Diverzificirana rast podjetja GMT d.o.o.

, 2018
The diploma project is divided into two parts. The first, theoretical part, presents the theory of growing companies and dynamic entrepreneurship, as well as the models and factors of company growth. The third chapter presents growth strategies and emphasizes diversified growth. GMT Ltd is later discussed based on this strategy.
openaire   +1 more source

Predictive factors and clinical outcomes following contemporary percutaneous coronary interventions for chronic total occlusions. [PDF]

Front Cardiovasc Med
Jin L, Youhu C, Huan W, Genrui C, Xiaolin L, Yue C, Chengxiang L, Haokao G.   +7 more
europepmc   +1 more source